Jocelyn Inamo
- Genetics top 5%
- Hemoglobinopathies and Related Disorders 7
- Hematology top 5%
-
- Blood Pressure and Hypertension Studies 15
- Cardiovascular Function and Risk Factors 8
- Cardiac Valve Diseases and Treatments 7
-
- Global Public Health Policies and Epidemiology 20
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 13
-
- Cardiac Structural Anomalies and Repair 7
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
- Co-authors
- Maurice Enriquez‐SaranoJean-François AviérinosBernard J. GershClarence ShubFrancesco GrigioniFrédéric GalactérosAnoosha HabibiLaurent Savale
- Journals
- New England Journal of Medicine (1 paper)SHILAP Revista de lepidopterología (1 paper)Blood (2 papers)
- Partner nations
- MartiniqueFranceGuadeloupe
In The Last Decade
Jocelyn Inamo
67 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 93
- Genetics 336
- Hematology 238
- Cardiology and Cardiovascular Medicine 437
- Organizational Behavior and Human Resource Management 81
- Pulmonary and Respiratory Medicine 244
Countries citing papers authored by Jocelyn Inamo
This map shows the geographic impact of Jocelyn Inamo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jocelyn Inamo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jocelyn Inamo more than expected).
Fields of papers citing papers by Jocelyn Inamo
This network shows the impact of papers produced by Jocelyn Inamo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jocelyn Inamo. The network helps show where Jocelyn Inamo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jocelyn Inamo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 5 | |
| 11 | 2020 | 29 | |
| 12 | 2019 | 11 | |
| 13 | 2018 | 1 | |
| 14 | 2018 | 2 | |
| 15 | 2016 | 4 | |
| 16 | [High blood pressure in populations with African ancestry: an increased vulnerability to target organ damage?]. | 2013 | 2 |
| 17 | 2011 | 15 | |
| 18 | 2009 | 9 | |
| 19 | 2007 | 19 | |
| 20 | [Access to care: not enough to completely abolish the disparity in hypertension management at the socio-economic level]. | 2006 | 3 |
About Jocelyn Inamo
Jocelyn Inamo is a scholar working on Organizational Behavior and Human Resource Management, Cardiology and Cardiovascular Medicine and Nephrology, having authored 79 papers that have together received 1.1k indexed citations. Recurring topics across this work include Global Public Health Policies and Epidemiology (20 papers), Blood Pressure and Hypertension Studies (15 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (13 papers), Cardiovascular Function and Risk Factors (8 papers), Cardiac Structural Anomalies and Repair (7 papers), Cardiac Valve Diseases and Treatments (7 papers), Hemoglobinopathies and Related Disorders (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). The work is most often cited by research in Genetics (336 citations), Hematology (238 citations) and Cardiology and Cardiovascular Medicine (437 citations). Jocelyn Inamo has collaborated with scholars based in Martinique, France and Guadeloupe. Frequent co-authors include Maurice Enriquez‐Sarano, Jean-François Aviérinos, Bernard J. Gersh, Clarence Shub, Francesco Grigioni, Frédéric Galactéros, Anoosha Habibi, Laurent Savale, Bernard Maître and Gérald Simonneau. Their work appears in journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.